Article Details

Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for ...

Retrieved on: 2024-11-19 19:09:24

Tags for this article:

Click the tags to see associated articles and topics

Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for .... View article details on hiswai:

Excerpt

This modifier gene therapy could potentially transform the landscape of GA treatment,” Hadziahmetovic said. Ocugen also reported promising data from ...

Article found on: www.ophthalmologytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up